Eli Lilly

Eli Lilly's Ramucirumab for lung cancer meets Phase III survival endpoint
Yahoo/Fly on the Wall
Wed, 02/19/14 - 08:41 am
Eli Lilly
ramucirumab
non-small cell lung cancer
Poor Pipeline Management Imperils Lilly's Future Cash Flows
Motley Fool
Mon, 02/17/14 - 03:22 pm
Eli Lilly
diabetes
insulin
Novo Nordisk
Sanofi
oncology
Alzheimer's disease
Can drug makers find profit in collaboration?
Forbes
Tue, 02/11/14 - 04:45 pm
NIH
Bristol-Myers Squibb
Pfizer
GSK
Eli Lilly
Merck
Amgen
Big Pharma Diversification: A Winning Model or Recipe for Disaster?
Motley Fool
Tue, 02/11/14 - 12:03 pm
Big Pharma
diversification
Merck
Eli Lilly
AbbVie
Abbott Laboratories
Pfizer
What's Big Pharma's latest hot spot? The Middle East
Fierce Pharma
Tue, 02/11/14 - 12:00 pm
Middle East
Merck
Merck Serono
Sanofi
Novo Nordisk
Eli Lilly
Bayer
The Effects Of Copycat Drugs on Novartis, Merck, and Eli Lilly
Motley Fool
Sat, 02/8/14 - 12:49 pm
Eli Lilly
Novartis
Merck
generics
Could These Potential Catalysts Drive Lilly Higher?
Motley Fool
Tue, 02/4/14 - 06:58 pm
Eli Lilly
Evista
Zyprexa
Cymbalta
generics
solanezumab
Alzheimer's disease
LY2963016
diabetes
empagliflozin
dulaglutide
Sanofi sues Eli Lilly over patents for top-selling insulin drug
Yahoo/Reuters
Fri, 01/31/14 - 08:06 am
Sanofi
Eli Lilly
insulin
diabetes
Lantus
Lilly Tops Earnings Estimates Despite Loss of Top Drug
Bloomberg
Thu, 01/30/14 - 10:04 am
earnings
Eli Lilly
Earnings Preview: Lilly pipeline comments anticipated in Q4 report
The Fly on the Wall
Wed, 01/29/14 - 02:54 pm
Eli Lilly
earnings
Ariad Pharma Short Seller Explains Why Takeover Rumor is Bunk
TheStreet.com
Mon, 01/27/14 - 12:20 pm
Ariad Pharmaceuticals
M&A
AP26113
Eli Lilly
Iclusig
This Week in Biotech: Clinical Success, Plus Wheeling and Dealing
Motley Fool
Sun, 01/26/14 - 10:46 am
BioDelivery Sciences
Endo Health Solutions
Karyopharm Therapeutics
Repligen
Biomarin
Ariad Pharmaceuticals
Eli Lilly
GSK
Shire
Ariad shares jump nearly 30% on rumors of Big Pharma takeover
Marketwatch
Fri, 01/24/14 - 06:01 pm
Ariad Pharmaceuticals
M&A
Eli Lilly
GSK
Shire
With Iclusig back to market, would Eli Lilly bid for Ariad? Would anyone?
Fierce Pharma
Fri, 01/24/14 - 09:12 am
Iclusig
M&A
Ariad Pharmaceuticals
Eli Lilly
Ariad Joins Rumor Mill: Hope May Trump Reality
Wall St 24/7
Thu, 01/23/14 - 11:06 am
Ariad Pharmaceuticals
Eli Lilly
M&A
Eli Lilly: 2014 Predictions
Seeking Alpha
Tue, 01/21/14 - 09:42 am
Eli Lilly
dulaglutide
empagliflozin
solanzemab
ramucirumab
Evista
Gemzar
Lilly buys back a migraine therapy from Arteaus Therapeutics
Fierce Biotech
Mon, 01/13/14 - 05:14 pm
Arteaus Therapeutics
migraines
Eli Lilly
Zymeworks pockets $15M, woos Lilly with its double-barreled antibodies
Fierce Biotech
Fri, 01/10/14 - 08:34 am
Zymeworks
oncology
Eli Lilly
Canada
antibodies
Amgen Vs. Merck, Lilly In Osteoporosis Competition
Seeking Alpha
Thu, 01/9/14 - 08:33 am
Amgen
Merck
Eli Lilly
osteoporosis
romosozumab
UCB Pharmaceuticals
Prolia
Forteo
Fosamax
New ED Drug: Analysis Of Vivus's Prospects
Seeking Alpha
Thu, 01/9/14 - 08:26 am
erectile dysfunction
Vivus
Stendra
Pfizer
Viagra
Cialis
Eli Lilly
Actavis
Auxillium
Bayer

Pages